609 related articles for article (PubMed ID: 12800080)
1. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
Issing WJ; Tauber S; Folwaczny C; Reichel O
Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
[TBL] [Abstract][Full Text] [Related]
2. [Manifestations of gastroesophageal reflux in the otorhinolaryngology tract].
Issing WJ; Gross M; Tauber S
Laryngorhinootologie; 2001 Aug; 80(8):464-9. PubMed ID: 11552426
[TBL] [Abstract][Full Text] [Related]
3. Dual-probe 24-hour ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux.
Issing WJ; Karkos PD; Perreas K; Folwaczny C; Reichel O
J Laryngol Otol; 2004 Nov; 118(11):845-8. PubMed ID: 15638969
[TBL] [Abstract][Full Text] [Related]
4. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
Ahmed TF; Khandwala F; Abelson TI; Hicks DM; Richter JE; Milstein C; Vaezi MF
Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
[TBL] [Abstract][Full Text] [Related]
6. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
[TBL] [Abstract][Full Text] [Related]
7. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.
Koufman JA
Laryngoscope; 1991 Apr; 101(4 Pt 2 Suppl 53):1-78. PubMed ID: 1895864
[TBL] [Abstract][Full Text] [Related]
8. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
9. The clinical characteristics of gastroesophageal reflux disease in patients with laryngeal symptoms who are referred to gastroenterology.
Oh JH; Choi MG; Park JM; Lim CH; Cho YK; Lee IS; Kim SW; Chung IS
Dis Esophagus; 2013 Jul; 26(5):465-9. PubMed ID: 22816650
[TBL] [Abstract][Full Text] [Related]
10. Acid reflux management: ENT perspective.
Ahmad I; Batch AJ
J Laryngol Otol; 2004 Jan; 118(1):25-30. PubMed ID: 14979968
[TBL] [Abstract][Full Text] [Related]
11. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
Ouatu-Lascar R; Triadafilopoulos G
Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
[TBL] [Abstract][Full Text] [Related]
12. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
Milkes D; Gerson LB; Triadafilopoulos G
Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
[TBL] [Abstract][Full Text] [Related]
13. Wireless pH monitoring in patients with non-cardiac chest pain.
Prakash C; Clouse RE
Am J Gastroenterol; 2006 Mar; 101(3):446-52. PubMed ID: 16542279
[TBL] [Abstract][Full Text] [Related]
14. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
[TBL] [Abstract][Full Text] [Related]
15. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
[TBL] [Abstract][Full Text] [Related]
16. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease.
Hershcovici T; Jha LK; Fass R
J Clin Gastroenterol; 2012 Aug; 46(7):562-6. PubMed ID: 22476040
[TBL] [Abstract][Full Text] [Related]
17. Association of laryngopharyngeal symptoms with gastroesophageal reflux disease.
Tauber S; Gross M; Issing WJ
Laryngoscope; 2002 May; 112(5):879-86. PubMed ID: 12150622
[TBL] [Abstract][Full Text] [Related]
18. [Gastroesophageal reflux involvement in ENT disorders].
Drug VL; Cobzeanu D; Papaghiuc C; Ciochină P; Gogălniceanu P; Bugioianoun C; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):220-2. PubMed ID: 16607774
[TBL] [Abstract][Full Text] [Related]
19. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.
Johnsson F; Hatlebakk JG; Klintenberg AC; Román J; Toth E; Stubberöd A; Falk A; Edin R
Scand J Gastroenterol; 2003 Apr; 38(4):354-9. PubMed ID: 12739706
[TBL] [Abstract][Full Text] [Related]
20. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
Katzka DA; Paoletti V; Leite L; Castell DO
Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]